The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMyhlth Chck Regulatory News (MHC)

Share Price Information for Myhlth Chck (MHC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 10.00
Bid: 9.50
Ask: 10.50
Change: 0.00 (0.00%)
Spread: 1.00 (10.526%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 10.00
MHC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Cond Subscription-Update re HMRC Advance Assurance

17 Feb 2021 07:00

RNS Number : 3090P
MyHealthChecked PLC
17 February 2021
 

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2018, AS AMENDED. ON PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

MyHealthChecked plc

("MyHealthChecked" or "the Company")

 

Conditional Subscription - Update re HMRC Advance Assurance

 

Further to the announcements of 29 January 2021, MyHealthChecked plc (AIM: MHC), the consumer home-testing healthcare company, announces it has now received Advance Assurance from HM Revenue and Customs that the ordinary shares to be issued are eligible for relief under the Enterprise Investment Scheme. This fulfils one of the conditions for the allotment of the 28,571,428 Conditional Subscription Shares detailed in the 29 January 2021 announcements.

 

The allotment of the Conditional Subscription Shares remains conditional, inter alia, upon approval by Shareholders of the Resolutions to be proposed at the General Meeting scheduled for 11.00 a.m. on 18 February 2021.

 

Application will be made for admission of the Conditional Subscription Shares to trading on AIM; it is expected that the Conditional Subscription Shares will be admitted to trading on AIM ("Admission") at 8.00 a.m. on or around 22 February 2021.

 

Total Voting Rights

Following Admission, the Company will have a total of 725,246,036 Ordinary Shares in issue with each Ordinary Share carrying the right of one vote. The above figure may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

Capitalised terms not otherwise defined in this announcement shall have the same meaning ascribed to such terms in the announcement released on 29 January 2021 unless the context requires otherwise.

 

For further information please contact:

 

 

MyHealthChecked plc

www.myhealthcheckedplc.com

Penny McCormick, Chief Executive Officer

via Walbrook PR

Maddy Kennedy, Chief Financial Officer

 

 

 

SPARK Advisory Partners Limited (NOMAD)

Tel: +44 (0)20 3368 3550

Neil Baldwin

 

 

 

Oberon Investments (Broker)

Tel: +44 (0)203 179 5344

Mike Seabrook

mikeseabrook@oberoninvestments.com

 

 

Walbrook PR Ltd (Media & Investor Relations)

Tel: +44 (0)20 7933 8780 or myhealthcheckedplc@walbrookpr.com

Paul McManus

Mob: +44(0)7980 541 893

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEAXAKFSXFEFA
Date   Source Headline
25th Mar 20227:00 amRNSIssue of Equity
16th Mar 20222:05 pmRNSSecond Price Monitoring Extn
16th Mar 20222:00 pmRNSPrice Monitoring Extension
7th Mar 20222:06 pmRNSSecond Price Monitoring Extn
7th Mar 20222:00 pmRNSPrice Monitoring Extension
3rd Mar 20221:05 pmRNSDirectorate Change
28th Feb 202211:05 amRNSSecond Price Monitoring Extn
28th Feb 202211:00 amRNSPrice Monitoring Extension
2nd Feb 20224:41 pmRNSSecond Price Monitoring Extn
2nd Feb 20224:36 pmRNSPrice Monitoring Extension
24th Jan 20227:00 amRNSTrading Update
5th Jan 20227:00 amRNSPartnership with Lloyds for COVID Antigen testing
13th Dec 20214:40 pmRNSSecond Price Monitoring Extn
13th Dec 20214:35 pmRNSPrice Monitoring Extension
13th Dec 20217:00 amRNSTrading update
7th Dec 20214:41 pmRNSSecond Price Monitoring Extn
7th Dec 20214:36 pmRNSPrice Monitoring Extension
1st Dec 20214:41 pmRNSSecond Price Monitoring Extn
1st Dec 20214:36 pmRNSPrice Monitoring Extension
1st Dec 202111:06 amRNSSecond Price Monitoring Extn
1st Dec 202111:00 amRNSPrice Monitoring Extension
29th Nov 202111:06 amRNSSecond Price Monitoring Extn
29th Nov 202111:01 amRNSPrice Monitoring Extension
26th Nov 202111:05 amRNSSecond Price Monitoring Extn
26th Nov 202111:00 amRNSPrice Monitoring Extension
25th Nov 202111:06 amRNSSecond Price Monitoring Extn
25th Nov 202111:00 amRNSPrice Monitoring Extension
24th Nov 20219:05 amRNSSecond Price Monitoring Extn
24th Nov 20219:00 amRNSPrice Monitoring Extension
24th Nov 20217:00 amRNSLaunch of COVID-19 rapid antigen test service
8th Oct 20214:41 pmRNSSecond Price Monitoring Extn
8th Oct 20214:36 pmRNSPrice Monitoring Extension
1st Oct 20217:00 amRNSBoard Change
29th Sep 20219:05 amRNSSecond Price Monitoring Extn
29th Sep 20219:00 amRNSPrice Monitoring Extension
29th Sep 20217:00 amRNSHalf-year Report
20th Sep 20212:01 pmRNSPrice Monitoring Extension
20th Sep 20217:00 amRNSStatement re. COVID-19 testing
17th Sep 20215:50 pmRNSStatement re. COVID-19 testing
13th Sep 20219:07 amRNSSecond Price Monitoring Extn
13th Sep 20219:03 amRNSPrice Monitoring Extension
7th Sep 20217:00 amRNSNotice of Results & Q3 Trading Update
1st Sep 20217:00 amRNSMedical laboratory accreditation for COVID testing
26th Aug 202111:05 amRNSSecond Price Monitoring Extn
26th Aug 202111:01 amRNSPrice Monitoring Extension
24th Aug 20217:00 amRNSStatement re. DHSC press release
30th Jul 20217:00 amRNSIssue of equity/PDMR Dealing
7th Jul 202111:06 amRNSSecond Price Monitoring Extn
7th Jul 202111:00 amRNSPrice Monitoring Extension
7th Jul 20219:06 amRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.